Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Oct 15;121(20):3717-26.
doi: 10.1002/cncr.29548. Epub 2015 Jul 20.

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial

Affiliations
Randomized Controlled Trial

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial

Anna M Sawka et al. Cancer. .

Abstract

Background: Patient decision aids (P-DAs) inform medical decision making, but longer term effects are unknown. This article describes extended follow-up from a thyroid cancer treatment P-DA trial.

Methods: In this single-center, parallel-design randomized controlled trial conducted at a Canadian tertiary/quaternary care center, early-stage thyroid cancer patients from a P-DA trial were contacted 15 to 23 months after randomization/radioactive iodine (RAI) decision making to evaluate longer term outcomes. It was previously reported that the use of the computerized P-DA in thyroid cancer patients considering postsurgical RAI treatment significantly improved medical knowledge in comparison with usual care alone. The P-DA and control groups were compared for the following outcomes: feeling informed about the RAI treatment choice, decision satisfaction, decision regret, cancer-related worry, and physician trust. In a subgroup of 20 participants, in-depth interviews were conducted for a qualitative analysis.

Results: Ninety-five percent (70 of 74) of the original population enrolled in follow-up at a mean of 17.1 months after randomization. P-DA users perceived themselves to be significantly more 1) informed about the treatment choice (P = .008), 2) aware of options (P = .009), 3) knowledgeable about treatment benefits (P = .020), and 4) knowledgeable about treatment risks/side effects (P = .001) in comparison with controls. There were no significant group differences in decision satisfaction (P = .142), decision regret (P = .199), cancer-related worry (P = .645), mood (P = .211), or physician trust (P = .764). In the qualitative analysis, the P-DA was perceived to have increased patient knowledge and confidence in decision making.

Conclusions: The P-DA improved cancer survivors' actual and long-term perceived medical knowledge with no adverse effects. More research on the long-term outcomes of P-DA use is needed.

Keywords: decision aids; decision making; decision support techniques; iodine radioisotopes; patient satisfaction; qualitative research; thyroid cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant flow in the study. RAI indicates radioactive iodine; RCT, randomized controlled study.

References

    1. Cancer Research UK. Thyroid cancer incidence statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/thyroid/in.... Accessed March 9, 2015.
    1. American Cancer Society . Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 2014.
    1. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, Canada: Canadian Cancer Society; 2014.
    1. EUCAN. Thyroid cancer. http://eco.iarc.fr/eucan/Cancer.aspx?Cancer=35. Accessed March 9, 2015.
    1. Sawka AM, Straus S, Gafni A, et al. A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision‐making on adjuvant radioactive iodine treatment. Patient Educ Couns. 2011;84:e24‐e27. - PubMed

Publication types